Utah AI Chatbot Prescribes Refills Without Doctor Review
Utah launched an AI chatbot program to automate prescription refills in January 2026 through a regulatory sandbox exemption, but the state medical board and health experts have raised concerns about drug interactions and safety risks, with board members calling for the program to be halted.
What happened
Utah launched an AI prescription refill program in January 2026 using the Doctronic chatbot, allowing residents to obtain prescription refills online without a doctor's visit through a state 'regulatory sandbox' that waived existing laws.
The program is overseen by a five-member board of AI specialists, none of whom are doctors. During its initial phase, human doctors review all Doctronic refill orders, but the company expects to transition to fully automated refills.
Reported impact
The program raised alarms among doctors, lawyers, and public health experts over AI's medical role, regulation, physician oversight, and patient safety. In March, 11 members of the Utah State Medical Licensing Board called for the program to be halted, citing risks of automatically renewing medicines with potential side effects or drug interactions.
The head of the state's medical licensing board said his colleagues learned of the program only when its launch was reported in news. Board members stated they were told the program was proceeding without their input despite their regulatory authority over medical professionals.
Index analysis
Current state and federal laws limit prescribing to licensed professionals. Dr. Eric Bressman of the University of Pennsylvania stated that the program represents 'giving something that is not human a medical license,' crossing a regulatory threshold.
Experts including Bressman said they are not opposed to AI prescribing but argue it should meet rigorous standards comparable to human doctors' training and testing. Medical technology is traditionally regulated federally while medical professionals are overseen by states, creating regulatory ambiguity.
Governance controls
The program operates under Utah's regulatory sandbox allowing state officials to waive laws for AI companies offering promising technology. The AI specialists board reports implementing numerous safeguards, including initial human doctor review of all refill orders.
Classification
Sources and evidence
Sources not yet published
This record was researched and written by the Index from original reporting. Its sources are still being verified by an editor, and they are listed here once that check is complete. Until then the record carries no reviewer.